Effects of clonidine on MMN and P3a amplitude in schizophrenia patients on stable medication

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Caitlyn KruiperBob Oranje

Abstract

Schizophrenia is a complex brain disease involving several neurotransmitter systems, including aberrant noradrenergic activity, which might underlie cognitive deficits. Clonidine is an α2A-agonist and previous research has demonstrated that single dosages of clonidine normalize sensori(motor) gating in schizophrenia. Currently, we investigated whether clonidine is able to normalize mismatch negativity (MMN) and P3a amplitude deficits in this same group of patients. This is important, since reports have shown that MMN amplitude is associated with cognitive functioning and daily life functions in schizophrenia. Twenty chronically ill, male schizophrenia patients were tested with the MMN paradigm from the Copenhagen Psychophysiological Test Battery (CPTB) on 5 occasions, separated by a week. Patients received randomized, yet balanced, either a placebo or a single dose (25, 50, 75 or 150 μg) of clonidine (each dose only once) on top of their usual medication on each occasion. Patients were matched on age and gender with 20 healthy controls (HC) who did not receive any treatment. We found decreased MMN and P3a amplitudes in our patients compared to HC. Although clonidine did neither significantly increase MMN nor P3a amplitude in ou...Continue Reading

References

Jun 1, 1990·Archives of General Psychiatry·J K WingN Sartorius
Feb 1, 1990·Archives of General Psychiatry·D L Braff, M A Geyer
Oct 15, 1996·Proceedings of the National Academy of Sciences of the United States of America·D C JavittJ C Arezzo
Sep 19, 1998·Electroencephalography and Clinical Neurophysiology·E HalgrenP Chauvel
Dec 5, 2002·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Seppo KähkönenIiro P Jääskeläinen
Nov 30, 2005·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·Torsten BaldewegKlaas E Stephan
Feb 17, 2007·Pharmacology & Therapeutics·Brian P Ramos, Amy F T Arnsten
Oct 13, 2007·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·R NäätänenK Alho
Nov 1, 2007·The International Journal of Neuropsychopharmacology·Bob OranjeBirte Y Glenthøj
Jul 14, 2010·Neuroscience and Biobehavioral Reviews·Anne-Kathrin J FettLydia Krabbendam
Sep 4, 2010·Journal of Clinical Psychopharmacology·Louise DuludeVerner J Knott
Nov 12, 2010·Nature·Thomas R Insel
Feb 25, 2011·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Amy F T Arnsten
Oct 25, 2011·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·Juanita ToddStanley V Catts
Nov 15, 2012·Schizophrenia Research·Eva María Sánchez-MorlaCelso Arango
Aug 9, 2013·JAMA Psychiatry·René S Kahn, Richard S E Keefe
Oct 10, 2013·Schizophrenia Bulletin·Bob Oranje, Birte Y Glenthøj
Jun 10, 2017·Neural Plasticity·Olga BorodovitsynaDaniel Chandler
Oct 17, 2017·Schizophrenia Bulletin·Holly K HamiltonDaniel H Mathalon

❮ Previous
Next ❯

Citations

Sep 4, 2020·Autism Research : Official Journal of the International Society for Autism Research·Emily J KnightJohn J Foxe

❮ Previous
Next ❯

Methods Mentioned

BETA
sedation

Software Mentioned

BESA
MEGIS
R
Presentation®

Related Concepts

Related Feeds

Auditory Perception

Auditory perception is the ability to receive and interpret information attained by the ears. Here is the latest research on factors and underlying mechanisms that influence auditory perception.